Skip to main content

Table 6 Refined scale composition with the six best-discriminating items per scale.

From: Development of an instrument to assess the impact of an enhanced experiential model on pharmacy students' learning opportunities, skills and attitudes: A retrospective comparative-experimentalist study

Number of patient Consulted: (F = 41.35, p < 0.000)*.

• Estimated number of consultations.

Learning Climate: (F = 3.88, p < 0.026).

• Preceptor encouraged patient follow-up.

• SPEP was significant in stimulating PC delivery to patients.

• Preceptor met with me on a regular basis to talk about patient issues.

• Clerkship gave me opportunities to practice and improve my PC skills.

• Preceptor identified activities for me to meet PC learning objectives.

• Preceptor encouraged me to provide evidence and justify my recommendations.

Learning Opportunities: (F = 3.23, p < 0.046).

• Document patient information in forms usable by other pharmacists.

• Provide follow-up (phone or in-person) using the monitoring plan.

• Discuss monitoring parameters with patients regarding their therapies.

• Determine whether patients are managing their medications or have questions.

• Prioritize drug-related problems so that most relevant problems get addressed first.

• Question patients to determine their experiences regarding drug effectiveness.

Skills Improvement: (F = 20.69, p < 0.000).

• Provide follow-up (phone or in-person) using the monitoring plan.

• Integrate information for patients with multiple problems to identify drug-related problems.

• Provide comprehensive PC to patients with fewer problems (4 or less).

• Integrate patient information to identify actual/potential drug-related problems.

• Prioritize drug-related problems so most relevant problems get addressed first.

• Document patient information in forms to be used by other pharmacists/practitioners.

Attitude Enhancement: (F = 6.86, p < 0.002).

• Disagrees: Follow-up is too time-consuming.

• Providing PC gives me a better understanding of patients' drug-related needs.

• Agrees: I am comfortable with the process of providing PC.

• Discussing monitoring parameters with patients is important.

• Disagrees: Follow-up is too expensive.

• Documenting care plans for continuity of care is important.

  1. * F and p values indicate the significance with which each scale discriminated between enhanced and control experiences.